Objective: To investigate the vasodilatory effect of Orthosiphon stamineus leaves using the activity-guided approach.
Introduction
Orthosiphon stamineus Benth, a Lamiaceae, popularly known in Southeast Asia as 'Misai Kucing' (Malaysia), 'Kumis Kucing' (Indonesia), and in Europe as 'Java Tea', is used traditionally as a remedy for capillary and circulatory disorders (e.g. arteriosclerosis), kidney stones, diabetes and nephritis [1] . In Southeast Asia, it is reputable in the traditional management of a variety of ailments, including urinary tract disorders, diabetes mellitus, hypertension, tonsillitis, rheumatism and menstrual disorders, fever, gout and jaundice [2, 3] . O.stamineus is listed in the French, Indonesian, Dutch, and Swiss pharmacopoeias for conditions related to renal cleansing and function, and related disorders that include nephritis, cystitis, and urethritis. It is also used as a remedy against high blood cholesterol and blood pressure [4] .
Several studies have investigated the biological and pharmacological effects of O.stamineus including its diuretic and anti-oxidant effects, as well as its beneficial effects on hyperglycemia and altered lipid profile in diabetic rats [5, 6] . The antipyretic and anti-inflammatory effects of the methanol extract have been reported in hyperthermia-induced rats and carraginine inflammed rats paw, respectively [7] . Furthermore, the inhibitory action of the plant extracts against Vibrio parahaemolyticus and Streptococcus mutans [8] and the hepatoprotective action [9] [10] [11] have been demonstrated. Extracts from this plant have been shown to enhance the cytotoxic action of tamoxifen against estrogen-dependent human breast cancer cells by 5-folds, i.e. anti-neoplastic effect, as well as suppressing the sprouting neovascularization of microvessels from the excised thoracic rat aorta, implying anti-angiogenic effect [12] . Most recently Mohammed et al [13] , in a genetotixicity study concluded that the use of O.stamineus in traditional medicine possesses no genotoxic risk.
There are currently a number of commercial products derived from this herb. [14] .
However, there is hardly any report available in the literature, to our knowledge, of work carried out on the cardiocascular effect of O.stamineus to provide a strong rationale or otherwise for its traditional usage in management of cardiovascular diseases such as hypertension. The present study therefore investigated the cardiovascular effect of extracts from O.stamineus. The activity-guided approach was used with the aim to understand at least in part, the possible mechanism of action as well as identify the chemical group responsible for the effect.
Materials and methods

Plant material
Fresh leaves of the plant Orthosiphon stamineus were collected from Kepala Batas, Seberang Perai, Pulau Penang Island, Malaysia. A voucher specimen (10106) was deposited at the herbarium of School of Biological Sciences, and another voucher specimen (027) deposited at Bilik Herba, School of Pharmaceutical Sciences, Universiti Sains Malaysia. The leaves were oven-dried (35-37ºC) to a constant weight. The dried leaves were grounded in an electric grinder to coarse powder (950 g), then packed into aluminium foil sheets of paper and kept in air-tight glass jars. About 600 g of the dried powdered material were extracted successively using a soxhlet apparatus with three solvents namely petroleum ether (60-80ºC), chloroform (45-50ºC) and methanol (60-80ºC). The residue from the methanol extraction, was finally extracted with water by maceration (60ºC) (Fig.1) . The extracts obtained from each solvent were then concentrated using a rotary evaporator (45-50ºC) to about 10% of the original volume and thereafter freeze-dried to yield 124 g (20.67%), 67 g (11.17%), 132 g (22.0%) and 74.5 g (12.42%) each of petroleum ether extract (PE), chloroform extract (CE), methanol extract (ME) and water extract (WE), respectively. These extracts were stored refrigerated from where aliquots were withdrawn for the experiments. 
Fractionation of the chloroform extract by drycolumn flash chromatography
The chloroform extract was found to be the most active in inhibiting noradrenaline-induced contraction of rat aortic strip preparation, therefore it was subjected to further fractionation. Sixty gram of silica gel (Merck, 7730) was packed into a glass column chromatography measuring 27 cm long and 5 cm in diameter fitted with a stopcock. With applied vacuum suction the silica was pressed gently and carefully around the circumference and then towards the center to produce a totally level, and well-compacted bed. The column was then preeluted under vacuum with 50 ml (x2) of hexane.
Pre-adsorption and application of the sample The chloroform extract was pre-adsorbed onto the adsorbent (silica gel) by dissolving 11 g of the extract in 200 ml of chloroform-methanol (CHCl 3 -MeOH, 1:1) followed by the addition of 20 g of the gel and mixed. Using a rotary evaporator the solvent was evaporated and the resultant dried sample mixture was applied onto the packed column and distributed evenly by applying suction.
Elution
The column was pre-eluted under vacuum with 50 ml (x2) petroleum ether and allowed to dry under suction. Thereafter, it was serially eluted with the following solvents: 450 ml of CHCl 3 -petroleum ether (30:70); 250 ml of CHCl 3 -petroleum ether (50:50); 250 ml of CHCl 3 (100%); 250 ml of MeOH-CHCl 3 (30:70); 250 ml MeOH-CHCl 3 (50:50) and finally with 250 ml of MeOH (100%).
Fixed-volume fractions were collected in prelabeled tubes and examined with thin layer chromatography. Fractions with identical RF (Retention Value) were pooled to obtain overall five fractions namely Cƒ 1 , Cƒ 2 , Cƒ 3 , Cƒ 4 and Cƒ 5. The fractions were concentrated in a rotary evaporator and further freeze-dried to yield 0.65 g (5.9%), 1.8 g (16.36%), 2.4 g (21.82%), 2.9 g (26.36%) and 2.0 g (18.18%) of Cƒ 1 , Cƒ 2 , Cƒ 3 , Cƒ 4 and Cƒ 5 , respectively. These were stored in a dissecator until pharmacological screening for their cardiovascular activity.
Animals Male Sprague-Dawley rats (220-250 g) obtained from the Animal Research and Service Centre (ARSC), Universiti Sains Malaysia (USM), were housed in the animal transit room, School of Pharmaceutical Sciences, USM. They were allowed free access to food (standard laboratory chow, Gold Coin Sdn. Bhd., Malaysia) and tap water. The animals were maintained according to accepted international and national guidelines and the procedure approved by the Animal Ethics Committee of USM (AECUSM).
Experimental procedure
The procedure described previously by Gilani et al [15] was used in this study. The rats were sacrificed by cervical dislocation and the aorta quickly isolated and placed in a petri dish containing Krebs solution aerated with 95% O 2 and 5% CO 2 at 37ºC. The preparations were cleaned from fatty tissue and cut into two to three short helical/spiral strips (about 7-10 mm long and 0.8 mm wide). One end of the aortic strip was tied to a tissue holder and then transferred to a 20 ml tissue bath filled with aerated Krebs physiological solution (g/L): NaCl (6.89), NaHCO 3 (2.1), MgSO 4 (0.29), KCl (0.37), KH 2 PO 4 (0.16), glucose (1.1) and CaCl 2 (0.28) [16] . The other end of the aortic strip was connected by means of a thread to a forcedisplacement transducer for isometric recording (Grass Polygraph Model 79D) under a resting tension of 0.5 g. The tissues were pre-contracted with the agonist, noradrenaline (10 -9 µg/ml), two to three times at the beginning of each experiment in order to reach baseline contraction. Thereafter, successive doses of the agonists (10 -9 , 3 х 10 -9 , 10 -8 , 3 х 10 -8 , 10 -7 , 3 х 10 -7 µg/ml) were added to the bath after the tissues have acquired steady-state equilibrium to the previous dose, until a maximum response/contraction was obtained. This data was used to construct a dose-response curve for the agonist. After the maximum response has been achieved, the agonist was washed off and the tissues allowed to completely relax. Three concentrations of the extracts (0.25, 0.5 and 1 mg/ml) prepared in Krebs solution were then added to the bath and allowed to equilibrate with the tissue for about 20 min. The tissue was again exposed to the agonist and a new dose-response curve obtained by using a range of doses of the agonist, which are sufficient to duplicate the initial dose-response curve. Similar dose-response curves were plotted for a wide range of extract concentrations. The response values obtained from different extract concentrations are expressed as a percentage of the agonist's maximum response (100%). The responses were repeatedly measured for 6-8 times using new tissues and the average of responses to each concentration of the agonist plotted on the ordinate, while the logarithm of the concentration of the agonist on the abscissa. The Krebs solution in the organ bath was replaced with fresh Krebs solution three times every 15-min intervals and the strip allowed to recover for 30 min before the next dose of extract is added.
Phytochemical evaluation of O.stamineus active extract and fraction.
The chloroform extract and Cƒ 2 fraction, and sinensetin, a standard flavonoid earlier isolated from the leaves of O.stamineus, were spotted on thin layer chromatography (TLC) plate and allowed to run using ethyl acetate: chloroform (7:3) as mobile phase. The chromatogram was developed using the natural product poly ethylene glycol (NP/PEG) reagent, and inspected under UV light at 365 nm.
HPLC study of active chloroform extract and standard sinensetin HPLC analysis of chloroform extract was performed using a Shimadzu-LC system (Japan) equipped with a CBM-20A controller, dual LC-20AT pumps, a DGU-20A5 degasser, an SIL-20A auto-sampler, an SPD-20AV detector and a CTO10ASvp column oven. Chromatographic separations were achieved using an Agilent Eclipse Plus C18 (250 x 4.6 mm i.d.; 5 µm). A Zorbax guard fittings kit packed with a replaceable Eclipse Plus C18 Guard column (12.5 x 4.6 mm i.d.; 5 µm) was used to protect the analytical column. A reversephase HPLC assay was carried out using an isocratic system with a flow rate of 1 ml/min, a column temperature of 25ºC, and a mobile phase of acetonitrile, isopropyl alcohol and 0.02 M phosphate buffer (NaH 2 PO 4 )(30:15:55, v/v) with pH adjusted to 3.5 using 85% phosphoric acid. The UV detection was set at 340 nm and the injection volume 20 µl. The total run time was less than 20 min for each injection. Data was acquired and processed using LC-Solution Software. The peaks were detected at 340 nm and identified using standard sinensetin.
Analysis of data
One-way analysis of variance (ANOVA) followed by Dunnet′s multiple comparison test was used to compare between groups using the computer software InStat 2. Data were expressed as percentage of the mean ± SEM and comparisons were considered significantly different at p < 0.05, p < 0.01 and p < 0.001.
Results
The effect of crude extracts on noradrenalineinduced contractions of isolated aortic strip preparations
It was found that the NA-induced contractions of the aortic strips were not significantly affected when incubated in the 0.25, 0.5 and 1 mg/ml of methanol extract of O.stamineus (Fig.2) . The petroleum ether and water extracts (Figs.3&4) showed inhibitory effects on the aortic contractions (p < 0.05 and p < 0.01, respectively), however, not at high doses of the agonist, NA. On the other hand, the chloroform extract inhibited the NA-induced contractions of the aortic strips at both low and high doses of the agonist (p < 0.001) (Fig.5) . At maximum response of NA, 0.25, 0.5 and 1 mg/ml of the chloroform extract inhibited the contractions by 8.5, 29 and 48%, respectively. Hence, a potent vasidilatory action.
The effect of fractions of chloroform extract on noradrenaline-induced contraction of isolated aortic strip preparations.
Of the five fractions obtained from the chloroform extract of O.stamineus, three (Cƒ 1, Cƒ 2 and Cƒ 3 ) were found to inhibit significantly adrenaline-induced contractions of the aortic strips, concentration-dependently (p < 0.05, 0.01 and 0.001, respectively) (Figs.6-8 ). Fractions Cƒ 4 and Cƒ 5 did not show any significant vasodilatory effects (Figs.9&10) . Among the three responsive fractions (Cƒ 1, Cƒ 2 and Cƒ 3 ), Cƒ 2 was found to exert the strongest inhibition on noradrenaline-induced contraction of rat aortic strip, hence considered the most effective with vasodilatory action (Fig.7) . At 0.5 and 1 mg/ml, Cƒ 2 inhibited the maximum noradrenaline-induced contraction by 16.5 and 49%, respectively.
Chemical groups present in the O.stamineus active extract and fraction
Inspection of the developed chromatogram under UV light at 365 nm reveals zones of fluorescents emitted by the chloroform extract and the fraction Cƒ 2 identical to sinensetin, indicating the presence flavonoids as the predominant chemical group (Fig.11 ). An HPLC analysis of the active chloroform extract of O.stamineus compared with pure sinensetin, performed at identical conditions of wavelength (340 nm) and retention time (20 min) also identified sinensetin in the extract (Fig.12) . Calculation based on simple linear regression curve revealed that the extract contained 30.907 ± 0.018 µg/mg of sinensetin. 
Discussion
Cardiovascular diseases are increasingly becoming one of the leading diseases causing morbidity and mortality in Malaysia and, indeed, the Southeast Asia. In the traditional system, Orthosiphon stamineus is widely employed as a remedy against these cardiovascular related diseases including hypertension, diabetes mellitus, arteriosclorosis, etc [2] [3] [4] . The present investigation was therefore carried out to provide a pharmacological rationale, if any, for this traditional practice. A simple in vitro method in assessing the ability of the extract to inhibit/vasodilate noradrenaline-induced contraction of an isolated rat aorta was used [15] . In the first phase of the experiments, it was found that the petroleum ether, chloroform and water extracts of Orthosiphon stamineus (but not the methanol extract), inhibited the noradrenaline-induced contraction of the isolated aorta. Of these three extracts, chloroform extract was the most effective in inhibiting the noradrenaline-induced contraction of the aorta, implying a potent vasodilatory activity. This observation suggests that the chemical groups responsible for the observed activity are predominant in the chloroform extract. Hence, the chloroform extract was further fractionated and the fractions obtained tested for vasodilatory effect. The result obtained for these fractions showed that the fraction Cƒ 2 was the most potent in vasodilating the noradrenaline-induced contraction of the aorta, which also implied that the active chemical groups were predominant in this fraction. These compounds were found in a qualitative TLC screening using a suitable mobile phase to be, flavonoids, most likely sinensetin. The qualitative assay result was supported with an HPLC analysis of the chloroform extract which revealed the amount of sinensetin in the extract to be about 30.907 ± 0.018 µg/mg. Although various chemical constituents have been isolated from the O.stamineus plant, the report on flavonoids in general, and sinensetin in particular, has been very consistent [1, 11] . The flavonoids (sinensetin) may be responsible for the observed vasodilatory effects, considering the fact that they were detected in the most effective fraction Cƒ 2 . In line with our submission, an earlier study by Duarte et al [17] indicated the direct vasodilatory effects of flavonoids on vascular smooth muscle in vitro. The claimed antihypertensive effect of O.stamineus extract can be attributed to the flavonoids contained therein.
It is likely from our observations in this study that O.stamineus exerts the vasodilatory action via mechanisms that are independent of the endothelium. Noradrenaline is known to produced contractions via the β 1 -adrenergic receptor, which works through the adenylate cyclase-cAMP system to activate G s -protein and eventually protein kinase A [18] . Also, according to Bolton et al [19] the NA-induced contractions are resistant to calcium-free conditions, and calcium-free conditions are mainly caused by mechanisms other than the opening of potential-sensitive calcium channels (entry and release of stored calcium). If NA elicits contraction by mechanisms which do not involve opening of potential-sensitive calcium channels, then by the same token the O.stamineus extract attenuation of NA-induced contraction must involve some mechanism other than opening potential-sensitive calcium channels. Hence, implicating an endothelium-independent mechanism. Moreover, Duarte et al [17] had in a preliminary investigation found that the in vitro vasodilatory effects of flavonoids are mainly endothelium-independent. In a later detailed study, reported that the main mechanism of flavonoidinduced vasodilatation results from the inhibition of protein kinases such as myosin light chain kinase (MLCK) and, possibly, other kinases involved in Ca 2+ -sensitizing mechanisms, e.g. protein kinase C and cyclic nucleotide phosphodiesterases [20] . There is therefore a high chance that O.stamineus may exert vasidilatory effect by a shared mechanism of the flavonoids.
In conclusion, although this work can only be considered as exploratory, taken together, evidence from this study suggests that O.stamineus contains a compound or a group of compounds with a cardiovascular activity on the aorta. This group of compounds is likely to be the flavonoids. The observed vasodilating properties of these compounds may be exerted via an endotheliumindependent mechanism. O.stamineus appears to be a potential natural source of ingredients for the management of cardiovascular disorders, hence warrants further research.
